Radcliffe Cardiology

Hyperlipidemia is considered a major risk factor of coronary artery disease. Characterised by abnormalities in lipid metabolism, this disorder increases the risk of atherosclerotic plaque formation in coronary arteries.

Radcliffe Cardiology Academy along with European Heart Rhythm Association (EHRA) has published the third issue of AER Journal Volume 3.

Moderated by Dr. Simon Kennon, the presentation explains how TAVI can be a safer alternative over the conventional open-heart surgery and why they are conducting randomised trials in intermediate risk patients.

Cardiology is a key medical speciality and witnesses a pace of change faster than ever. Not only in the medical therapy, but technological advancements to the catheterization lab, electrophysiology and interventional procedures.

The healthcare arena has been witnessing a major shift in its landscape with the advent of cutting edge technologies and state-of-the-art equipment.

If there is a middle ground between medical therapy and surgical treatments for cardiology, it is called interventional cardiology – a subspecialty that focuses primarily on catheterization performed on a functioning heart.

As the role of percutaneous coronary intervention (PCI) has evolved, so too has the technology associated with this specialty. This has led to the evolution of more dynamic, effective stents.